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Introduction
 In general, taking care of breast cancer is quite 
complex and costly (Rosselli et al., 2010). Moreover, 
investors, consumers, and providers are highly interested 
in measuring the quality of cancer care and emphasize 
obtaining high-quality information (Pearson et al., 
2002). Care quality measurement is a mechanism which 
quantifies the quality of a dimension of care by comparing 
the services provided for the patients with the standard 
criteria (Malin et al., 2002; Moher et al., 2004). The 
present study has focused on the process of care quality. 
According to the evidence, the better the process of cancer 
care, the more desirable the results will be.
 Up to now, a large number of studies have confirmed 
the relationship between the process and output of breast 
cancer care (Rosselli et al., 2010). In general, the data 
provide the opportunity for measuring the care quality 
(Moher et al., 2004) and the best data resources for 
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 Objectives: To investigate data agreement of cancer registries and medical records as well as the quality of 
care and assess their relationship in a 5-year period from 2006 to 2011. Methods: The present cross-sectional, 
descriptive-analytical study was conducted on 443 cases summarized through census and using a checklist. 
Data agreement of Nemazi hospital-based cancer registry and the breast cancer prevention center was analyzed 
according to their corresponding medical records through adjusted and unadjusted Kappa. The process of care 
quality was also computed and the relationship with data agreement was investigated through chi-square test. 
Results: Agreement of surgery, radiotherapy, and chemotherapy data between Nemazi hospital-based cancer 
registry and medical records was 62.9%, 78.5%, and 81%, respectively, while the figures were 93.2%, 87.9%, 
and 90.8%, respectively, between breast cancer prevention center and medical records. Moreover, quality of 
mastectomy, lumpectomy, radiotherapy, and chemotherapy services assessed in Nemazi hospital-based cancer 
registry was 12.6%, 21.2%, 35.2%, and 15.1% different from the corresponding medical records. On the other 
hand, 7.4%, 1.4%, 22.5%, and 9.6% differences were observed between the quality of the above-mentioned 
services assessed in the breast cancer prevention center and the corresponding medical records. A significant 
relationship was found between data agreement and quality assessment. Conclusion: Although the results 
showed good data agreement, more agreement regarding the cancer stage data elements and the type of the 
received treatment is required to better assess cancer care quality. Therefore, more structured medical records 
and stronger cancer registry systems are recommended. 
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evaluating the quality of cancer care are medical records 
and hospital cancer registrations (Coory, 2009). Overall, 
in order for the data resources to accurately assess the 
quality of care, reliable data on the intended care must be 
available (Malin et al., 2002). 
 In fact, the best way for data validation is comparing 
the registered data with the main source (Malin et al., 
2002; Ferlay, 2005) and data validity can be used in 
case the main source is the gold standard. This is not 
usually possible in reality and, as a result, data agreement 
should be utilized (Guanmin, 2009). Therefore, in the 
present study, the process of breast cancer care quality 
for the cases registered in Nemazi hospital-based cancer 
registry (NHBCR) and breast cancer prevention center 
(BCPC) affiliated to Shiraz University of Medical 
Sciences, Shiraz, Iran was analyzed according to their 
corresponding medical records and the relationship 
between the data agreement and assessment of care quality 
was investigated, as well.
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Materials and Methods
 In this study, the medical records corresponding to all 
the cancer cases registered in NHBCR and BCPC of Shiraz 
University of Medical Sciences, Shiraz, Iran in 2006 
(315 and 388 cases, respectively) were collected using 
the demographic characteristics. Then, all the medical 
records were integrated and the patients who had medical 
profiles, were diagnosed with stages I, II, and III of cancer, 
were female, and lived in Fars province were enrolled 
into the study. Afterwards, the medical records were 
summarized regarding the data related to chemotherapy, 
radiotherapy, lumpectomy, mastectomy, hormone therapy, 
tumor features and spread, initial treatment, demographic 
characteristics, and existence of co-morbidities using 
Charlson co-morbidity index which has been standardized 
for breast cancer (Charlson, 1987) for 5 years after cancer 
diagnosis. After summarization, 238 and 205 cases 
revealed to have the inclusion criteria of the study in BCPC 
and HBCR, respectively. It should be noted that the data 
elements of the summarization instrument were obtained 
from American Joint Commission on Cancer (AJCC) 
(Edge and Compton, 2010), Charlson index (Charlson, 
1987), similar studies (Malin et al., 2002; Moher et al., 
2004), national standards, and the experts’ opinions. 
Moreover, the reliability of the summarization instrument 
was confirmed by a number of experts.
 Overall, the study was conducted in 3 stages: 
investigation of data agreement, assessment of care 
quality, and determination of the relationship between data 
agreement and care quality assessment. In the first stage, 
data agreement of the intended variables was determined 
by comparing the resources and using observed agreement, 
unadjusted kappa, and adjusted kappa, such as prevalence 
adjusted bias adjusted kappa (PABAK), bias adjusted 
kappa (BAK), and weighted kappa (WK) (Byrt, 1993; 
Hoehler, 2000; Ben-David, 2008). Then, the rate of data 
agreement was interpreted based on the kappa ranges; i.e., 
0 (weak), 0.1-0.2 (mild), 0.21-0.40 (almost average), 0.41-
0.60 (average), 0.61-0.80 (good), and 0.81-1 (excellent) 
(Sim and Wright, 2005). In the second step, cancer 
care quality was assessed using the following 4 quality 
indicators (QI) obtained from national (Partoeipour, 2010) 
and the experts’ opinions:
 QI1: The patients with stage I through III breast cancer 
should have chemotherapy. QI2: The patients with stage 
III breast cancer who have undergone mastectomy and 
their tumor is equal to or more than 5 cm as well as those 
with stage I or II breast cancer who have had mastectomy 
and their lymph node is positive should have radiotherapy. 
QI3: The patients with stage I or II breast cancer, those 
with stage III breast cancer whose tumor is equal to or 
more than 5 cm, and stage I, II, or III breast cancer patients 
over 70 years old should have mastectomy. QI4: The 
patients with stage I or II breast cancer, those with stage 
III breast cancer whose tumor is less than 5 cm, and stage 
I, II, or II breast cancer patients over 70 years old should 
have lumpectomy.
 According to the above-mentioned indicators, if a case 
was located in an indicator and had received the standard 
care, the care quality was scored as 1 out of 1 or 100%. 
Moreover, if a case was engaged in 3 indicators and had 
received the standard care in 2 cases, the care quality was 
scored as 2 out of 3 or 66%.In order to assess the quality 
of care, the variables of age, co-morbidities (based on 
Charlson’s table of co-morbidities, cancer stage (I, II, or 
III), and type of inpatient or outpatient care were computed 
in percentile and compared with each other.Finally, 
chi-square was used in order to analyze the relationship 
between data agreement and care quality assessment. All 
the statistical analyses were performed through the SPSS 
statistical software (v. 16) and SAS software.
Results 
 According to the results obtained from the 4 data 
resources, the highest incidence of breast cancer had 
occurred between 40 and 49 years of age and stage II was 
the most prevalent cancer stage at the time of diagnosis.
 Based on the data of the medical records corresponding 
to NHBCR, 71.7%, 28.3%, 81.5%, and 90.2% of 
the patients had received mastectomy, lumpectomy, 
radiotherapy, and chemotherapy, respectively. These 
measures were reported as 58%, 10.2%, 62.9%, and 
71.2%, respectively based on the NHBCR data. In addition, 
100% of the patients according to the medical records and 
68.3% according to the NHBCR data had undergone 
surgery. Furthermore, the rate of receiving chemotherapy, 
radiotherapy, mastectomy, and lumpectomy in the medical 
records of the patients below and equal to or above 50 
years old was 89.1-91.9%, 84-77.9%, 67.2-77.9%, and 
32.8-22.1%, respectively. These measures were reported 
as 67.8-75.6%, 64.3-61.1%, 55.7-61.1%, and 10.4-10%, 
respectively in NHBCR.
 Based on the data of the medical records corresponding 
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Table 1. Agreement of Care Data of Cancer Registry 
Centers and their Corresponding Medical Records
 BCPC MR NHBCR MR 
 PABAK Kappa Agree N     N PABAK Kappa Agree N     N
Inpatient Care
 Lumpectomy 0.843 0.738 62.30 58 21 0.874 0.863 93.7 71 72
 Mastectomy    147 119    163 155
Outpatient Care 
 Chemotherapy 0.619 0.422 81.00 185 146 0.816 0.483 90.8 226 204
 Radiotherapy 0.671 0.487 78.50 167 129 0.757 0.734 87.9 171 143
*MR: Medical record, N: Number, Agree: %agreement
Table 2. Agreement of Non-Care Data of Cancer 
Registry Centers and their Corresponding Medical 
Records
 BCPC MR NHBCR MR
 WK BAK Kappa Agree No   No WK BAK Kappa Agree No   No
Stage
 1 0.912 0.882 0.901 78 25 20 0.989 0.981 0.984 87.9 41 39
 2     104 85     137 121
 3     76 65     60 52
 Unknown    0 35     0 26
Co -morbidity
 Have     151 181     186 0
 Don’t, have 
  0.516 0.668 0.505 0.516 54 24 NA NA NA NA 61 0
ER, PR receptor 
  0.527 0.5 0.319 49.8 154 53 0.991 0.965 0.972 98.3 234 232
*NA: Not applicable, N: Number, WK: Weighted kappa, BAK: Bias adjusted 
kappa, ER: Estrogen, PR: Progestron
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to BCPC, 69.3%, 30.3%, 73.1%, and 87.2% of the patients 
had undergone mastectomy, lumpectomy, radiotherapy, 
and chemotherapy, respectively, while these measures 
were reported as 66.2%, 30.8%, 61.1%, and 71.2%, 
respectively in BCPC. Besides, surgery was performed 
for 100% of the patients according to the medical records 
and 96.6% according to the BCPC data. Moreover, the 
rate of chemotherapy, radiotherapy, mastectomy, and 
lumpectomy in the medical records of the patients below 
and equal to or above 50 years old was 97-92.2%, 77.8-
64.1%, 63.7-76.7%, and 35.6-22.3%, respectively. On 
the other hand, this rate was reported as 86.6-84.6%, 
67.2-51%, 60.4-71.2%, and 35.8-23.1%, respectively in 
BCPC.
 Regarding NHBCR and medical records, data 
agreement of outpatient services was higher than that 
of inpatient services. Moreover, the study findings 
revealed good, average, and average kappa for surgery, 
chemotherapy, and radiotherapy, respectively. Of course, 
by applying PABAK and eliminating the prevalence and 
bias effects, the rate of kappa increased for all the cases. 
PABAK showed to be excellent for surgery, while it was 
found to be good for chemotherapy as well as radiotherapy 
(Table 1).Considering BCPC and medical records, on 
the other hand, data agreement of inpatient services was 
higher than that of the outpatient services. Furthermore, 
the study results showed excellent, average, and good 
kappa for surgery, chemotherapy, and radiotherapy, 
respectively. PABAK was also revealed to be excellent, 
excellent, and good, respectively (Table 1).
 Overall, the agreement between NHBCR data and the 
medical records related to age, marital status, histology of 
cancer, nuclear grade, and histology grade was reported as 
100%, 91.7%, 98%, 100%, and 76.1%, respectively. On 
the other hand, the agreement between the BCPC data and 
the medical records on the above-mentioned variables was 
100%, 80.3%, 96.21%, 100%, and 95%, respectively. It 
should be noted that BCPC did not collect the data related 
to the co-morbidities and, consequently, data agreement 
could not be computed in this regard (Table 2).
 NHBCR data reported the assessed quality of 
mastectomy, lumpectomy, radiotherapy, and chemotherapy, 
respectively 12.6%, 21.2%, 35.2%, and 15.1% lower 
than the medical records. Moreover, the results obtained 
from the medical records corresponding to NHBCR 
showed that the quality of chemotherapy, radiotherapy, 
and mastectomy was lower among the cases with co-
morbidities. In addition, the quality of radiotherapy and 
mastectomy was lower in equal to or above 50 ages (Table 
3).
 On the other hand, BCPC data reported the quality of 
mastectomy, lumpectomy, radiotherapy, and chemotherapy, 
respectively 7.4%, 1.4%, 22.5%, and 9.6% lower than the 
medical records. Besides, the results obtained fromthe 
medical records corresponding to BCPC also showed 
that the quality of chemotherapy, radiotherapy, and 
mastectomy was lower in the cases accompanied by co-
morbidities. Nevertheless, due to the lack of information 
about co-morbidities in BCPC,the process of care 
qualitycould not be assessed (Table 4).
 Overall, the findings of the study revealed significant a 
relationship between the data agreement of chemotherapy, 
radiotherapy, and surgery and assessing the quality of these 
services. A statistically significant relationship was also 
found between cancer stage data agreement and assessing 
the quality of each of the above-mentioned services 
(P<0.05).
Discussion
The findings of the present study showed that the 
agreement of the BCPC data was higher than that of the 
NHBCR data, which might be due to the fact that the 
patients’ status is followed up in shorter time intervals in 
BCPC. Moreover, in NHBCR, agreement of the outpatient 
care data was better than that of the inpatient care data, 
which is consistent with the results of the study by 
Brewster (Brewster, 2002). Considering the BCPC data, 
on the other hand, the agreement of inpatient care data was 
higher than that of the outpatient care data, which is in line 
with the findings of the studies conducted by Gulliford 
(1993), Moher et al. (2004), and Zhang (2010). This 
Table 3. Quality of Breast Cancer Care in NHBCR and its Corresponding Medical Records
 NHBCR MR
 NCo     Co     S3     S2     S1     <50     >50     All NCo       Co       S3       S2       S1       <50       >50       All
Lumpectomy 100 100 100 100 100 100 100 100 76.9 100 87.5 71.4 100 66.7 86.7 77.8
Mastectomy 90.2 78.6 68.8 100 100 82.9 90.5 87 72.2 68.7 46.9 91.2 86.7 72.9 75.7 74.4
Radiotherapy after surgery
  80.6 70.8 68.9 85.7 78.9 71.4 82.2 78 45 37.5 47.3 36.7 57.1 36.7 47.5 42.9
Chemotherapy 91.4 85.2 92.1 88.5 88 90.7 89.1 89.8 74.3 77.8 77 72.6 80 75.7 67.9 74.7 
*Co: Co-Morbidities, NCo: No any Co-Morbidities, S: Stage
Table 4. Quality of Breast Cancer Care in BCPC and its Corresponding Medical Records
 NHBCR MR
 NCo     Co     S3     S2     S1     <50     >50     All NCo       Co       S3       S2       S1       <50       >50       All
Lumpectomy 100 100 100 100 100 100 100 100 NA NA 88.9 100 100 100 97.9 98.6
Mastectomy 89.3 82.9 60.8 100 95.2 83.5 90.6 87.2 NA NA 39 98.7 94.7 76.8 82.9 79.9
Radiotherapy after surgery
  78.9 75.6 67.8 77.6 88 67.1 81.3 75.9 NA NA 47.2 59.3 79.2 58.1 60.2 59.4
Chemotherapy 95.5 94.2 100 92.7 95.1 93.2 96.3 95 NA NA 82.4 85 89.7 86 84.9 85.4
*Co: Co-Morbidities, NCo: No any Co-Morbidities, S: Stage
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difference might result fromthe close relationship between 
chemotherapy and radiotherapy wards andNHBCR.
Overall, in comparison to the radiotherapy data, 
chemotherapy data agreement was higher in both centers, 
which is consistent with the studies by Zhang (2010) 
and Elbasmi (1987), while on the contrary to the results 
obtained by Moher et al. (2004).
The study results also showed better agreement of the 
demographic data compared to the care data. The studies 
conducted by Elbasmi (1987) and Pollock and Vickers 
(1995) have also shown that the highest data agreement 
is related to demographic and non-medical data. The low 
agreement of the care data might be due to being more 
specialized, the need for more knowledgeable specialists 
for cancer registration and summarization of the medical 
records, undesirable structure of the medical records, and 
lack of 6-month follow up of the patients’ data.
In the current study, compared to radiotherapy, 
chemotherapy services benefited a higher agreement with 
the standards after the surgery. This was also confirmed by 
the findings of the studies by McEvoy et al. (2004), Wyld 
(2004), Guadagnoli et al. (1998), and Malin et al (2002).
The study results showed that age and co-morbidities 
reduced thequality of radiotherapy and mastectomy. 
Besides, as the age increased, using radiotherapy after the 
surgery decreased. These findings are in line with those of 
the studies conducted by Farrow (1992), Ballard-Barbash 
(1996), and Schuster (1998).
Furthermore, considering the fact that most of the 
cases were with stage II breast cancer at the moment of 
diagnosis, cancers can be diagnosed in the first stage by 
regular, complete screening which, consequently, results 
in increasing the quality of care.
The study findings showed that the data agreement of 
chemotherapy, radiotherapy, surgery, cancer stage, and 
tumor size caused a significant difference in assessing 
the quality of care. In other words, the difference in the 
care quality measured in the two centers showed the low 
quality of the data for being used in assessing the quality 
care. In the same line, the results of the study by Bickell 
and Chassin (2000) and Malin et al. (2002) showed that 
insufficient reporting of chemotherapy and radiotherapy 
for breast cancer in hospital registrations directly affected 
the care quality assessment. Yulei also performed a 
study in order to measure the quality of cancer care by 
combining the medical records and the cancer registration 
data. The results obtained from assessment of care quality 
in both data resources and comparison of the two showed 
that direct utilization of cancer registration data led to the 
unreliability of the analysis (Yulei and Zaslavsky, 2009).
In this study, although the data of estrogen and 
progesterone receptors were available in both the medical 
records and BCPC, the quality of care could not be 
assessed due to the incompleteness or no registration of 
hormone therapy data in the medical records as well as 
the cancer registration resources. Smith also conducted 
a study on the inequality of the data in medical records 
and cancer registry centers for evaluating the cancer 
services and faced problems, including incomplete data 
details, low follow up of the care data, incomplete data 
registration, and incomplete registration of the details for 
the patients who had received a part of their care service 
in other treatment centers. Besides, since he was not 
able to find any data regarding the estrogen receptors,he 
could not evaluate the quality of hormone therapy 
services. Therefore, incomplete data is one of the greatest 
limitations in assessing cancer services in cancer registry 
centers (Smith et al., 1997).
Overall, although the study results showed desirable 
data agreement, more agreement regarding the cancer stage 
data elements as well as the type of the received treatment 
is required in order to assess the process of cancer care 
quality. Therefore, more structured medical records and 
stronger cancer registry systems are recommended.
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